RxDoctor Payments Data

Jorge Marcet, MD

Colon & Rectal Surgery · Tampa, FLNPI 1447269337

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 35.6% of the total.

$73,707in general payments, 2019–2025

Across 140 payments — averaging $526.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$26K
  • Intuitive Surgical$16K
  • Stryker$12K
  • Covidien LP$10K
  • Applied Medical Resources Corporation$5K
  • Baxter Healthcare$1K
  • plus $3K from 10 others
$553,037in research payments, 2019–2025

Across 554 payments — averaging $998.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$345K
  • AbbVie$83K
  • Janssen Research & Development, LLC$64K
  • Bristol Myers Squibb$44K
  • Roche Products Limited$9K
  • Bausch Health US, LLC$8K

What the payments were for

  • Consulting fees$22,32830%
  • Speaking & faculty fees$31,19242%
  • Travel & lodging$7,43510%
  • Food & beverage$6,2538%
  • Education$6,5009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,707 in reported general payments places this provider in the 85th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$69,162
Medicare patients
94
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate29$126
Metronidazole30$37

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →